NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells. Bottoni L, Minetti A, Realini G, Pio E, et al. Oncogene 2024 Apr 10. doi: 10.1038/s41388-024-03025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bottoni L, Minetti A, Realini G, Pio E, et al. NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells. Oncogene 2024 Apr 10. doi: 10.1038/s41388-024-03025.
PMID: 38600165